Timing is critical, controversial A concise synopsis of recent research data and current guidelines on when to initiate antiretroviral therapy, which regimens to choose, and how to monitor response and side effects.

Log in or subscribe to view full content.
Article is also available for purchase the article in one of the available formats.
Paul A. Volberding, MD

Table of Contents

Postgraduate Medicine:

Volume 115 No. 2


Clinical Features

Purchase this article in one of the formats specified below:

DOI: 10.3810/pgm.2004.02.1441
Abstract: Currently available antiretroviral drug regimens are able to suppress HIV replication and allow CD4 recovery in the vast majority of patients with HIV infection. The challenge is to match each patient to the regimen that is most likely to durably suppress HIV replication enough to prevent resistance selection without causing treatment-limiting toxicities. It is also critical, but difficult, to know when to begin treatment relative to CD4 cell count and plasma viral load. In this article, Dr Volberding addresses the central questions surrounding antiretroviral treatment initiation and reviews some available treatment options.